| pubmed-article:9873746 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9873746 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:9873746 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:9873746 | lifeskim:mentions | umls-concept:C0360105 | lld:lifeskim |
| pubmed-article:9873746 | lifeskim:mentions | umls-concept:C1511539 | lld:lifeskim |
| pubmed-article:9873746 | lifeskim:mentions | umls-concept:C1948027 | lld:lifeskim |
| pubmed-article:9873746 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
| pubmed-article:9873746 | lifeskim:mentions | umls-concept:C2936520 | lld:lifeskim |
| pubmed-article:9873746 | lifeskim:mentions | umls-concept:C0243072 | lld:lifeskim |
| pubmed-article:9873746 | pubmed:issue | 23 | lld:pubmed |
| pubmed-article:9873746 | pubmed:dateCreated | 1999-1-21 | lld:pubmed |
| pubmed-article:9873746 | pubmed:abstractText | Hybrid molecules built up by covalent coupling of aminopropanol derivatives (especially pindolol) with antidepressant drugs like fluoxetine, paroxetine or milnacipran were found to be potent and silent 5-HT1A antagonists (KB < 1 nM for 7c and 9a). | lld:pubmed |
| pubmed-article:9873746 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9873746 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873746 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9873746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9873746 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9873746 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:9873746 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:9873746 | pubmed:author | pubmed-author:PerezMM | lld:pubmed |
| pubmed-article:9873746 | pubmed:author | pubmed-author:PauwelsP JPJ | lld:pubmed |
| pubmed-article:9873746 | pubmed:author | pubmed-author:PalmierCC | lld:pubmed |
| pubmed-article:9873746 | pubmed:author | pubmed-author:HalazySS | lld:pubmed |
| pubmed-article:9873746 | pubmed:author | pubmed-author:ChopinPP | lld:pubmed |
| pubmed-article:9873746 | pubmed:author | pubmed-author:FourrierCC | lld:pubmed |
| pubmed-article:9873746 | pubmed:author | pubmed-author:Pallard-Sigog... | lld:pubmed |
| pubmed-article:9873746 | pubmed:author | pubmed-author:ColovrayVV | lld:pubmed |
| pubmed-article:9873746 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9873746 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:9873746 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:9873746 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9873746 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9873746 | pubmed:pagination | 3423-8 | lld:pubmed |
| pubmed-article:9873746 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:9873746 | pubmed:meshHeading | pubmed-meshheading:9873746-... | lld:pubmed |
| pubmed-article:9873746 | pubmed:meshHeading | pubmed-meshheading:9873746-... | lld:pubmed |
| pubmed-article:9873746 | pubmed:meshHeading | pubmed-meshheading:9873746-... | lld:pubmed |
| pubmed-article:9873746 | pubmed:meshHeading | pubmed-meshheading:9873746-... | lld:pubmed |
| pubmed-article:9873746 | pubmed:meshHeading | pubmed-meshheading:9873746-... | lld:pubmed |
| pubmed-article:9873746 | pubmed:meshHeading | pubmed-meshheading:9873746-... | lld:pubmed |
| pubmed-article:9873746 | pubmed:meshHeading | pubmed-meshheading:9873746-... | lld:pubmed |
| pubmed-article:9873746 | pubmed:meshHeading | pubmed-meshheading:9873746-... | lld:pubmed |
| pubmed-article:9873746 | pubmed:meshHeading | pubmed-meshheading:9873746-... | lld:pubmed |
| pubmed-article:9873746 | pubmed:meshHeading | pubmed-meshheading:9873746-... | lld:pubmed |
| pubmed-article:9873746 | pubmed:meshHeading | pubmed-meshheading:9873746-... | lld:pubmed |
| pubmed-article:9873746 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9873746 | pubmed:articleTitle | Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors. | lld:pubmed |
| pubmed-article:9873746 | pubmed:affiliation | Medicinal Chemistry, Centre de Recherche Pierre Fabre, Castres, France. michel.perez@pierre-fabre.com | lld:pubmed |
| pubmed-article:9873746 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:9873746 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9873746 | lld:pubmed |
